AAP 2022 Bilirubin

AAP 2022 hyperbilirubinemia management guideline with phototherapy, escalation, and exchange transfusion thresholds

Clinically Verified· 10 tests

For educational and informational purposes only. Verify all results before clinical application.

hours
mg/dL

Neurotoxicity risk factors: isoimmune hemolytic disease, G6PD deficiency, asphyxia, significant lethargy, temperature instability, sepsis, albumin <3.0 g/dL, or gestational age 35-37 weeks.

References

  1. Kemper AR, Newman TB, Slaughter JL, et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;150(3):e2022058859.[DOI]

Reviewed by Daniel Diaz-Gil, MD · Last updated March 2026

Medical disclaimer

This tool is for educational and informational purposes only. It is not a substitute for professional clinical judgment. Always independently verify results before making clinical decisions.